List of insiders holdings for OPIANT PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Ki Seijin Director |
2010-03-25 15:32:24 | 0 5,000,000 |
5,000,000 | Form 5 |
| 2 | Pollack Kevin See Remarks |
2018-10-09 16:05:54 | 148,834 0 |
148,834 | Form 13D |
| 3 | WOLF GEOFFREY 10% Owner |
2018-04-17 12:11:22 | 124,500 0 |
124,500 | Form 4 |
| 4 | Mottiwala Aziz Chief Commercial Officer |
2019-09-20 16:06:14 | 50,000 0 |
50,000 | Form 3 |
| 5 | Thompson Rahsaan General Counsel |
2019-09-20 16:04:51 | 40,000 0 |
40,000 | Form 3 |
| 6 | Silver Gabrielle Alison Director |
2023-03-03 09:27:04 | 0 0 |
0 | Form 4 |
| 7 | Belmont Partners LLC Meuse Joseph J 10% Owner |
2009-08-26 09:58:40 | 0 0 |
0 | Form 4 |
| 8 | Ruth Matthew R. Chief Commercial Officer |
2023-03-03 09:22:53 | 0 0 |
0 | Form 4 |
| 9 | Daly Richard J Director |
2023-03-03 09:20:53 | 0 0 |
0 | Form 4 |
| 10 | CRYSTAL ROGER Chief Executive Officer 10% Owner |
2023-03-03 09:18:59 | 0 0 |
0 | Form 4 |
| 11 | Ellison Mark Jason Heath Chief Development Officer |
2023-03-03 09:16:40 | 0 0 |
0 | Form 4 |
| 12 | Sinclair Michael Director 10% Owner |
2023-03-03 09:10:52 | 0 0 |
0 | Form 4 |
| 13 | MacDougall Ann L. Director |
2023-03-03 09:08:29 | 0 0 |
0 | Form 4 |
| 14 | Lorianne Masuoka K. Director |
2023-03-03 09:05:53 | 0 0 |
0 | Form 4 |
| 15 | Gorman Brian General Counsel |
2023-03-03 09:03:12 | 0 0 |
0 | Form 4 |
| 16 | Thomas Thomas T. Director |
2023-03-03 09:00:20 | 0 0 |
0 | Form 4 |
| 17 | O'Toole David D Chief Financial Officer |
2023-03-03 08:57:07 | 0 0 |
0 | Form 4 |
| 18 | Collard Craig A Director |
2023-03-03 09:25:03 | 0 0 |
0 | Form 4 |
| 19 | Skolnick Phil Chief Scientific Officer |
2023-03-03 09:13:19 | 0 0 |
0 | Form 4 |